Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12868845 | 0.78 | CETP (0.46) | CETPPKM | |
| SCHEMBL1492602 | 0.78 | CETP (0.46) | CETPPKM | |
| SCHEMBL7530106 | 0.78 | CETP (0.46) | CETPPKM | |
| SCHEMBL461557 | 0.78 | CETP (0.46) | CETPPKM | |
| SCHEMBL459896 | 0.76 | CETP (0.56) | CETPPKM | |
| Hydrochloric Acid SCHEMBL7425924 | 0.76 | CETP (0.43) | CETPPKM | |
| SCHEMBL21375711 | 0.75 | — | — | |
| SCHEMBL7171615 | 0.74 | CETP (0.42) | CETPPKM | |
| Calcium SCHEMBL9561192 | 0.74 | CETP (0.53) | CETPPKM | |
| SCHEMBL7181118 | 0.74 | CETP (0.53) | CETPPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159528-A1 | VMAT2 INHIBITORS AND METHODS OF USE | NEUROCRINE BIOSCIENCES, INC. | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159528-A1 | VMAT2 INHIBITORS AND METHODS OF USE | SLC18A2, SLC6A3, SLC6A2 | CETP 1253/4885PKM 866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.